Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2018

Sep 28, 2018

35119_dirs_2018-09-28_9f426963-bb44-4973-afa4-de529bdd5466.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2018-09-27

Reporting Person: Brownlie Keith L (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-27 Stock Option (Right to Buy) $1.67 A 17964 Acquired 2028-09-26 Common Stock (17964) Direct

Footnotes

F1: The stock option vests ratably on each of December 27, 2018, March 27, 2019, June 27, 2019 and September 27, 2019.